These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 18050221

  • 21. Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
    Buch MH, Bingham SJ, Bejarano V, Bryer D, White J, Reece R, Quinn M, Emery P.
    Arthritis Rheum; 2007 Apr 15; 57(3):448-53. PubMed ID: 17394231
    [Abstract] [Full Text] [Related]

  • 22. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ, Isern RA, Cooley DA, Harshbarger JL, Huffstutter JE, Hughes GM, Spencer-Smith EA, Goldman AL, Roth SH, Toder JS, Warner D, Quinn A, Keenan GF, Schaible TF, PROMPT Study Group. Profiling Remicade Onset with MTX in a Prospective Trial.
    J Rheumatol; 2002 Apr 15; 29(4):667-77. PubMed ID: 11950005
    [Abstract] [Full Text] [Related]

  • 23. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R, Sander O, van Riel P, van de Putte L, Hasler F, Zaug M, Kneer J, van der Auwera P, Stevens RM, Rheumatology Group 791.
    J Rheumatol; 2003 Apr 15; 30(4):680-90. PubMed ID: 12672184
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
    Bathon JM, Fleischmann RM, Van der Heijde D, Tesser JR, Peloso PM, Chon Y, White B.
    J Rheumatol; 2006 Feb 15; 33(2):234-43. PubMed ID: 16465653
    [Abstract] [Full Text] [Related]

  • 25. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria.
    Arthritis Rheum; 2007 Mar 15; 57(2):193-202. PubMed ID: 17330293
    [Abstract] [Full Text] [Related]

  • 26. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA, Tacrolimus RA Study Group.
    Rheumatology (Oxford); 2004 Aug 15; 43(8):992-9. PubMed ID: 15014199
    [Abstract] [Full Text] [Related]

  • 27. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW, Weinblatt ME, Keystone EC, Kremer JM, Martin RW, Schiff MH, Whitmore JB, White BW.
    J Rheumatol; 2006 May 15; 33(5):854-61. PubMed ID: 16541481
    [Abstract] [Full Text] [Related]

  • 28. Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial.
    Le Loët X, Nordström D, Rodriguez M, Rubbert A, Sarzi-Puttini P, Wouters JM, Woolley JM, Wright N, Lawrence C, Appleton B.
    J Rheumatol; 2008 Aug 15; 35(8):1538-44. PubMed ID: 18634163
    [Abstract] [Full Text] [Related]

  • 29. Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis.
    McGonagle D, Tan AL, Madden J, Taylor L, Emery P.
    Rheumatology (Oxford); 2008 Jun 15; 47(6):865-7. PubMed ID: 18390581
    [Abstract] [Full Text] [Related]

  • 30. Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study.
    van den Bemt BJ, den Broeder AA, Snijders GF, Hekster YA, van Riel PL, Benraad B, Wolbink GJ, van den Hoogen FH.
    Ann Rheum Dis; 2008 Dec 15; 67(12):1697-701. PubMed ID: 18245109
    [Abstract] [Full Text] [Related]

  • 31. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
    Genovese MC, Kaine JL, Lowenstein MB, Del Giudice J, Baldassare A, Schechtman J, Fudman E, Kohen M, Gujrathi S, Trapp RG, Sweiss NJ, Spaniolo G, Dummer W, ACTION Study Group.
    Arthritis Rheum; 2008 Sep 15; 58(9):2652-61. PubMed ID: 18759293
    [Abstract] [Full Text] [Related]

  • 32. Titration of infliximab treatment in rheumatoid arthritis patients based on response patterns.
    Flendrie M, Creemers MC, van Riel PL.
    Rheumatology (Oxford); 2007 Jan 15; 46(1):146-9. PubMed ID: 16782732
    [Abstract] [Full Text] [Related]

  • 33. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
    van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, Freundlich B, Chang DJ, Etanercept Study 400 Investigators.
    Ann Rheum Dis; 2008 Feb 15; 67(2):182-8. PubMed ID: 17728331
    [Abstract] [Full Text] [Related]

  • 34. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
    Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group.
    Arthritis Rheum; 2006 Jun 15; 54(6):1987-94. PubMed ID: 16732547
    [Abstract] [Full Text] [Related]

  • 35. Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.
    Jois RN, Masding A, Somerville M, Gaffney K, Scott DG.
    Rheumatology (Oxford); 2007 Jun 15; 46(6):980-2. PubMed ID: 17384180
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.
    Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA.
    J Rheumatol; 2004 Dec 15; 31(12):2356-9. PubMed ID: 15570634
    [Abstract] [Full Text] [Related]

  • 37. Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years.
    Strand V, Balbir-Gurman A, Pavelka K, Emery P, Li N, Yin M, Lehane PB, Agarwal S.
    Rheumatology (Oxford); 2006 Dec 15; 45(12):1505-13. PubMed ID: 17062648
    [Abstract] [Full Text] [Related]

  • 38. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs.
    Popa C, Leandro MJ, Cambridge G, Edwards JC.
    Rheumatology (Oxford); 2007 Apr 15; 46(4):626-30. PubMed ID: 17189244
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.
    Dougados M, Emery P, Lemmel EM, de la Serna R, Zerbini CA, Brin S, van Riel P.
    J Rheumatol; 2003 Dec 15; 30(12):2572-9. PubMed ID: 14719196
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul 15; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.